Work

Linvoseltamab (LINVO) Monotherapy in Patients (pts) with Newly Diagnosed (ND) Multiple Myeloma (MM): Initial Dose-Escalation Results from the Window of Opportunity LINKER-MM4 Trial

Year: 2025

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(25)03494-9

Authors: Christopher Ferreri, Mansi Shah, Rajshekhar Chakraborty, Don Stevens, Aurora Breazna, Oluwaseun Aina, Anita Boyapati, Colby Shemesh, Steven Quatela, Robert Orlowski

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414303703

FWCI:

Cites:

Cited by:

Related to: 10